Effect of narrowband ultraviolet B therapy on inflammatory markers and body fat composition in moderate to severe psoriasis

British Journal of Dermatology

Volumn 166, Issue 6, 2012, Pages 1237-1244

  Romani J ^a   Caixas A ^a   Carrascosa, J M ^b   Ribera, M ^a   Rigla, M ^a   Luelmo, J ^a  

^a PARC TAULÍ HOSPITAL UNIVERSITARI   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; C REACTIVE PROTEIN; CARBOHYDRATE; CYANOCOBALAMIN; FERRITIN; FOLIC ACID; HOMOCYSTEINE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PYRIDOXINE; VITAMIN D;

ADULT; ANTHROPOMETRY; ARTICLE; ATHEROGENESIS; BODY FAT; BODY MASS; CALCIUM METABOLISM; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FERRITIN BLOOD LEVEL; FOLIC ACID BLOOD LEVEL; HUMAN; INFLAMMATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NARROWBAND ULTRAVIOLET B THERAPY; OUTCOME ASSESSMENT; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; SPAIN; ULTRAVIOLET B RADIATION; WAIST CIRCUMFERENCE;

ADULT; BIOLOGICAL MARKERS; BODY FAT DISTRIBUTION; BODY MASS INDEX; CALCIFEDIOL; CARBOHYDRATE METABOLISM; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PSORIASIS; SPAIN; TREATMENT OUTCOME; ULTRAVIOLET THERAPY; WAIST CIRCUMFERENCE;

EID: 84861644879     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.10883.x     Document Type: Article

References (40)

1. Gelfand JM, Troxel AB, Lewis JD, et al. The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol 2007; 143: 1493-9.
2. Boehncke WH, Boehncke S, Tobin AM, Kirby B,. The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular morbidity. Exp Dermatol 2011; 20: 303-7.
3. Gisondi P, Girolomoni G,. Cardiometabolic comorbidities and the approach to patients with psoriasis. Actas Dermosifiliogr 2009; 100: 14-21.
4. Gottlieb AB, Dann F,. Comorbidities in patients with psoriasis. Am J Med 2009; 122: 1150.
5. Boehncke S, Salgo R, Garbaraviciene J, et al. Effective continuous systemic treatment of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study. J Eur Acad Dermatol Venereol 2011; 17: 1-7.
6. Prey S, Paul C, Bronsard V, et al. Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies. J Eur Acad Dermatol Venereol 2010; 24: 23-30.
7. Wakkee M, Herings RM, Nijsten T,. Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort. J Invest Dermatol 2010; 130: 962-7.
8. Gerdes S, Rostami-Yazdi M, Mrowietz U,. Adipokines and psoriasis. Exp Dermatol 2011; 20: 81-7.
9. Johnston A, Arnadottir S, Gudjonsson JE, et al. Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation. Br J Dermatol 2008; 159: 342-50.
10. Jin Y, Zhang F, Yang S, et al. Combined effects of HLA-Cw6, body mass index and waist-hip ratio on psoriasis vulgaris in Chinese Han population. J Dermatol Sci 2008; 52: 123-9.
11. Binkley N, Novotny R, Krueger D, et al. Low vitamin D status despite abundant sun exposure. J Clin Endocrinol Metab 2007; 92: 2130-5.
12. Peters BS, dos Santos LC, Fisberg M, et al. Prevalence of vitamin D insufficiency in Brazilian adolescents. Ann Nutr Metab 2009; 54: 15-21.
13. Diffey BL,. Is casual exposure to summer sunlight effective at maintaining adequate vitamin D status? Photodermatol Photoimmunol Photomed 2010; 26: 172-6.
14. Morimoto S, Kunihiko Y, Fukuo K, et al. Inverse relation between severity of psoriasis and serum 1,25-dihydroxy-vitamin D level. J Dermatol Sci 1990; 1: 277-82.
15. Vähävihu K, Ala-Houhala M, Peric M, et al. Narrowband ultraviolet B treatment improves vitamin D balance and alters antimicrobial peptide expression in skin lesions of psoriasis and atopic dermatitis. Br J Dermatol 2010; 163: 321-8.
16. Ryan C, Moran B, McKenna MJ, et al. The effect of narrowband UV-B treatment for psoriasis on vitamin D status during wintertime in Ireland. Arch Dermatol 2010; 146: 836-42.
17. Foss YJ,. Vitamin D deficiency is the cause of common obesity. Med Hypotheses 2009; 72: 314-21.
18. Osmancevic A, Landin-Wilhelmsen K, Larkö O, et al. UVB therapy increases 25 (OH) vitamin D syntheses in postmenopausal women with psoriasis. Photodermatol Photoimmunol Photomed 2007; 23: 172-8.
19. Juzeniene A, Stokke KT, Thune P, Moan J,. Pilot study of folate status in healthy volunteers and in patients with psoriasis before and after UV exposure. J Photochem Photobiol, B 2010; 101: 111-16.
20. Tobin AM, Hughes R, Hand EB, et al. Homocysteine status and cardiovascular risk factors in patients with psoriasis: a case-control study. Clin Exp Dermatol 2011; 36: 19-23.
21. Carrascosa JM, Gardeazábal J, Pérez-Ferriols A, et al. Documento de consenso sobre fototerapia: terapias PUVA y UVB de banda estrecha. Actas Dermosifiliogr 2005; 96: 635-58.
22. Kyle UG, Bosaeus I, De Lorenzo AD, et al. Bioelectrical impedance analysis-part I: review of principles and methods. Clin Nutr 2004; 23: 1226-43.
23. Basra MK, Fenech R, Gatt RM, et al. The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008; 159: 997-1035.
24. Alberti KG, Zimmet P, Shaw J,. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-80.
25. Ferrannini E, Mari A,. How to measure insulin sensitivity. J Hypertens 1998; 16: 895-905.
26. Gavrila D, Salmerón D, Egea-Caparrós JM, et al. Prevalence of metabolic syndrome in Murcia Region, a southern European Mediterranean area with low cardiovascular risk and high obesity. BMC Public Health 2011; 11: 562.
27. Arias-Santiago S, Ruiz-Carrascosa JC, Sierra M, et al. Prevalence of metabolic syndrome in patients with severe psoriasis. Med Actual 2009; 94: 12-17.
28. Uvanik BS, Ari Z, Onur E, et al. Serum lipids and apolipoproteins in patients with psoriasis. Clin Chem Lab Med 2002; 40: 65-8.
29. Akhyani M, Ehsani AH, Robati RM, Robati AM,. The lipid profile in psoriasis: a controlled study. J Eur Acad Dermatol Venereol 2007; 21: 1330-2.
30. Channual J, Wu JJ, Dann FJ,. Effects of tumor necrosis factor-alpha blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis. Dermatol Ther 2009; 22: 61-73.
31. Osmancevic A, Nilsen LT, Landin-Wilhelmsen, et al. Effect of climate therapy at Gran Canaria on vitamin D production, blood glucose and lipids in patients with psoriasis. J Eur Acad Dermatol Venereol 2009; 23: 1133-40.
32. Czarnecki D,. Narrowband ultraviolet B therapy is an effective means of raising serum vitamin D levels. Clin Exp Dermatol 2008; 33: 202. (Letter).
33. Norwal M, Björn LO, De Gruijl FR,. Is the action spectrum for the UV-induced production of previtamin D3 in human skin correct? Photochem Photobiol Sci 2010; 9: 11-17.
34. Carrascosa JM, Bigatà X,. UVB terapia de banda estrecha: experiencia en la práctica clínica y factores predictivos de respuesta. Actas Dermosifiliogr 2000; 91: 555-62.
35. Coimbra S, Oliveira H, Reis F, et al. Circulating levels of adiponectin, oxidized LDL and C-reactive protein in Portuguese patients with psoriasis vulgaris, according to body mass index, severity and duration of the disease. J Dermatol Sci 2009; 55: 202-4.
36. Ghosh A, Mukhopadhyay S, Kar M,. Role of free reactive iron in psoriasis. Indian J Dermatol Venereol Leprol 2008; 74: 277-8.
37. Cicarma E, Mørk C, Porojnicu AC, et al. Influence of narrowband UVB phototherapy on vitamin D and folate status. Exp Dermatol 2010; 19: 67-72.
38. Nielsen KP, Zhao L, Stamnes JJ, et al. The importance of the depth distribution of melanin in skin for DNA protection and other photobiological processes. J Photochem Photobiol, B 2006; 82: 194-8.
39. Kwon HH, Kwon IH, Choi JW, Youn JI,. Cross-sectional study on the correlation of serum uric acid with disease severity in Korean patients with psoriasis. Clin Exp Dermatol 2011; 36: 473-8.
40. Nijsten T, Wakee M,. Complexity of the association between psoriasis and comorbidities. J Invest Dermatol 2009; 129: 1601-3.